|
1
|
Tang ZY, Yu YQ, Zhou XD, Ma ZC and Wu ZQ:
Progress and prospects in hepatocellular carcinoma surgery. Ann
Chir. 52:558–563. 1998.PubMed/NCBI
|
|
2
|
Zhou XD, Tang ZY, Yu YQ, et al: Recurrence
after resection of alpha-fetoprotein-positive hepatocellular
carcinoma. J Cancer Res Clin Oncol. 120:369–373. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bismuth H, Chiche L, Adam R, Castaing D,
Diamond T and Dennison A: Liver resection versus transplantation
for hepatocellular carcinoma in cirrhotic patients. Ann Surg.
218:145–151. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jaeck D, Bachellier P, Oussoultzoglou E,
Weber JC and Wolf P: Surgical resection of hepatocellular
carcinoma. Post-operative outcome and long-term results in Europe:
an overview. Liver Transpl. 10(2 Suppl 1): S58–S63. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El-Serag HB, Marrero JA, Rudolph L and
Reddy KR: Diagnosis and treatment of hepatocellular carcinoma.
Gastroenterology. 134:1752–1763. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kabilova TO, Kovtonyuk LV, Zonov EV, et
al: Immunotherapy of hepatocellular carcinoma with small
double-stranded RNA. BMC Cancer. 14:338–349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Breous E and Thimme R: Potential of
immunotherapy for hepatocellular carcinoma. J Hepatol. 54:830–834.
2011. View Article : Google Scholar
|
|
8
|
Srivastava P: Roles of heat-shock proteins
in innate and adaptive immunity. Nat Rev Immunol. 2:185–194. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ravoet C, Bleiberg H and Gerard B:
Non-surgical treatment of hepatocarcinoma. J Surg Oncol Suppl.
3:104–111. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zinkernagel RM: Immunity against solid
tumors? Int J Cancer. 93:1–5. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Correale P, Cusi MG, Tsang KY, et al:
Chemo-immunotherapy of metastatic colorectal carcinoma with
gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte
macrophage colony-stimulating factor and interleukin-2 induces
strong immunologic and antitumor activity in metastatic colon
cancer patients. J Clin Oncol. 23:8950–8958. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Correale P, Cusi MG, Del Vecchio MT, et
al: Dendritic cell-mediated cross-presentation of antigens derived
from colon carcinoma cells exposed to a highly cytotoxic multidrug
regimen with gemcitabine, oxaliplatin, 5-fluorouracil and
leucovorin, elicits a powerful human antigen-specific CTL response
with antitumor activity in vitro. J Immunol. 175:820–828. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Skoberne M, Beignon AS, Larsson M, et al:
Apoptotic cells at the crossroads of tolerance and immunity. Curr
Top Microbiol Immunol. 289:259–292. 2005.PubMed/NCBI
|
|
14
|
Kleinclauss F, Perruche S, Masson E, et
al: Intravenous apoptotic spleen cell infusion induces a
TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ.
13:41–52. 2006. View Article : Google Scholar
|
|
15
|
Zheng L, He M, Long M, Blomgran R and
Stendahl O: Pathogen-induced apoptotic neutrophils express heat
shock proteins and elicit activation of human macrophages. J
Immunol. 173:6319–6326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feng H, Zeng Y, Whitesell L and Katsanis
E: Stressed apoptotic tumor cells express heat shock proteins and
elicit tumor-specific immunity. Blood. 97:3505–3512. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Korbelik M, Sun J and Cecic I:
Photodynamic therapy-induced cell surface expression and release of
heat shock proteins: relevance for tumor response. Cancer Res.
65:1018–1026. 2005.PubMed/NCBI
|
|
18
|
Liu B, DeFilippo AM and Li Z: Overcoming
immune tolerance to cancer by heat shock protein vaccines. Mol
Cancer Ther. 1:1147–1151. 2002.PubMed/NCBI
|
|
19
|
Clark PR and Ménoret A: The inducible
Hsp70 as a marker of tumor immunogenicity. Cell Stress Chaperones.
6:121–125. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li CL, Meng X, Lang ZW and Zhang LJ: The
detection of heat shock protein gp96 in primary hepatocellular
carcinoma. Zhonghua Gan Zang Bing Za Zhi. 12:569–570. 2004.In
Chinese. PubMed/NCBI
|
|
21
|
Udono H and Srivastava PK: Comparison of
tumor-specific immunogenicities of stress-induced proteins gp96,
hsp90, and hsp70. J Immunol. 152:5398–5403. 1994.PubMed/NCBI
|
|
22
|
Lancaster GI and Febbraio MA:
Exosome-dependent trafficking of HSP70: A novel secretory pathway
for cellular stress proteins. J Biol Chem. 280:23349–23355. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brusa D, Migliore E, Garetto S, Simone M
and Matera L: Immunogenicity of 56 degrees C and UVC-treated
prostate cancer is associated with release of HSP70 and HMGB1 from
necrotic cells. Prostate. 69:1343–1352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Beg AA: Endogenous ligands of Toll-like
receptors: implications for regulating inflammatory and immune
responses. Trends Immunol. 23:509–512. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matzinger P: The danger model: a renewed
sense of self. Science. 296:301–305. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nowak AK, Robinson BW and Lake RA: Synergy
between chemotherapy and immunotherapy in the treatment of
established murine solid tumors. Cancer Res. 63:4490–4496.
2003.PubMed/NCBI
|
|
27
|
Ménoret A, Chaillot D, Callahan M and
Jacquin C: Hsp70, an immunological actor playing with the
intracellular self under oxidative stress. Int J Hyperthermia.
18:490–505. 2002. View Article : Google Scholar
|
|
28
|
Singh-Jasuja H, Scherer HU, Hilf N, et al:
The heat shock protein gp96 induces maturation of dendritic cells
and down-regulation of its receptor. Eur J Immunol. 30:2211–2215.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Millar DG, Garza KM, Odermatt B, et al:
Hsp70 promotes antigen-presenting cell function and converts T-cell
tolerance to autoimmunity in vivo. Nat Med. 9:1469–1476. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tamura Y, Peng P, Liu K, Daou M and
Srivastava PK: Immunotherapy of tumors with autologous
tumor-derived heat shock protein preparations. Science.
278:117–120. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schild H, Arnold-Schild D, Lammert E and
Rammensee HG: Stress proteins and immunity mediated by cytotoxic T
lymphocytes. Curr Opin Immunol. 11:109–113. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sato K, Torimoto Y, Tamura Y, et al:
Immunotherapy using heat-shock protein preparations of leukemia
cells after syngeneic bone marrow transplantation in mice. Blood.
98:1852–1857. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pawel S and Anne MD: The immunosuppressive
activity of heat shock protein 70. Autoimmune Diseases. 2012:1–6.
2012.
|
